Healthcare -
Biotechnology - NASDAQ - US
$ 2.74
12.8 %
$ 134 M
Market Cap
-1.27
P/E
Price Target
Average
639.05%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
--1.08%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cabaletta Bio, Inc.
Wall Street analysts predict an average 1-year price target for CABA of $20.2 , with forecasts ranging from
a
low of
$3 to a high of $32 .
CABA Lowest Price Target
Wall Street Target
3 USD
9.49%
CABA Average Price Target
Wall Street Target
20.2 USD
639.05%
CABA Highest Price Target
Wall Street Target
32 USD
1067.88%
REVENUE FORECAST
Revenue Forecast Chart CABA
EBIT FORECAST
EBIT Forecast Chart CABA
NET INCOME FORECAST
Net Income Chart CABA